Tuesday, December 27, 2011

Prevention of peritoneal adhesions: A promising role for gene therapy

More Good News for those who suffer from Adhesion Related Disorder!

Source: World J Gastroenterol


Prevention of peritoneal adhesions: A promising role for gene therapy; Atta HM; World Journal of Gastroenterology 17 (46), 5049-58 (Dec 2011)


Adhesions are the most frequent complication of abdominopelvic surgery, yet the extent of the problem, and its serious consequences, has not been adequately recognized. Adhesions evolved as a life-saving mechanism to limit the spread of intraperitoneal inflammatory conditions. Three different pathophysiological mechanisms can independently trigger adhesion formation. Mesothelial cell injury and loss during operations, tissue hypoxia and inflammation each promotes adhesion formation separately, and potentiate the effect of each other. Studies have repeatedly demonstrated that interruption of a single pathway does not completely prevent adhesion formation. This review summarizes the pathogenesis of adhesion formation and the results of single gene therapy interventions. It explores the promising role of combinatorial gene therapy and vector modifications for the prevention of adhesion formation in order to stimulate new ideas and encourage rapid advancements in this field.

http://www.docguide.com/prevention-peritoneal-adhesions-promising-role-gene-therapy?tsid=5

No comments: